(HealthDay)—Variations across hospitals and surgeons in patient-reported outcomes following elective lumbar fusion surgery are mainly driven by differences in patient
Continue reading »
In a medical first, a trauma patient was put into a state of suspended animation
New Scientist reports that a team of doctors working at the University of Maryland School of Medicine has, for the
Continue reading »
Drawing on a love of art, she’s gone from patient to healer
A red wagon. A blue easel. A sunny atrium. Katie Hinson remembers those snippets of her childhood stay in the
Continue reading »
New polymer heart valve implanted in first patient
Caltech researchers have helped to design a new generation of heart valves that are longer-lasting, cost less to manufacture, and
Continue reading »
Patient charges mean young people visit doctor less
When young adults pass the age limit for paying patient co-payments, or out-of-pocket prices, their medical consultations in primary care
Continue reading »
Surgeon does ‘world first’ brain surgery on patient 1,800 MILES AWAY
Surgeon performs ‘world first’ remote brain surgery on a Parkinson’s patient 1,800 MILES AWAY using machines controlled over 5G mobile
Continue reading »
What the ‘London patient’ means for HIV/AIDS research
The “London Patient” is only the second person known to have shaken off the HIV virus during a 40-year AIDS
Continue reading »
2nd ever HIV patient in remission after stem cell transplant: Doctors
A man who previously tested positive for HIV has shown no trace of the virus that causes AIDS since receiving
Continue reading »
Genomic testing of a single patient reveals a gene commonly mutated in pediatric melanoma
Comprehensive clinical genomic testing of an adolescent patient, including whole genome sequencing, helped researchers identify mutations in a single gene
Continue reading »
Theravance Biopharma Announces First Patient Dosed in Registrational Phase 3 Study of Ampreloxetine (TD-9855) for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension
DUBLIN, Jan. 28, 2019 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of
Continue reading »